Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 501801, 14 pages
http://dx.doi.org/10.1155/2013/501801
Review Article

Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection

Department of Pediatrics, University of Minnesota Medical School, Center for Infectious Diseases and Microbiology Translational Research, 2001 6th Street SE, Minneapolis, MN 55455, USA

Received 4 February 2013; Accepted 7 March 2013

Academic Editor: Philipp Henneke

Copyright © 2013 Mark R. Schleiss. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kenneson and M. J. Cannon, “Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection,” Reviews in Medical Virology, vol. 17, no. 4, pp. 253–276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Wang, X. Zhang, S. Bialek, and M. J. Cannon, “Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection,” Clinical Infectious Diseases, vol. 52, no. 2, pp. e11–e13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. L. Nyholm and M. R. Schleiss, “Prevention of maternal cytomegalovirus infection: current status and future prospects,” International Journal of Women's Health, vol. 2, no. 1, pp. 23–35, 2010. View at Google Scholar · View at Scopus
  4. S. E. Oliver, G. A. Cloud, P. J. Sánchez et al., “Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system,” Journal of Clinical Virology, vol. 46, supplement 4, pp. S22–S26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Whitley, “Congenital cytomegalovirus infection: epidemiology and treatment,” Advances in Experimental Medicine and Biology, vol. 549, pp. 155–160, 2004. View at Google Scholar · View at Scopus
  6. K. B. Fowler, S. Stagno, and R. F. Pass, “Maternal immunity and prevention of congenital cytomegalovirus infection,” Journal of the American Medical Association, vol. 289, no. 8, pp. 1008–1011, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Y. Yamamoto, M. M. Mussi-Pinhata, S. B. Boppana et al., “Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population,” American Journal of Obstetrics and Gynecology, vol. 202, no. 3, pp. 297.e1–297.e8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. E. C. Swanson and M. R. Schleiss, “Congenital cytomegalovirus infection: new prospects for prevention and therapy,” Pediatric Clinics of North America, vol. 60, no. 2, pp. 335–349, 2013. View at Google Scholar
  9. B. N. Bristow, K. A. O'Keefe, S. C. Shafir, and F. J. Sorvillo, “Congenital cytomegalovirus mortality in the United States, 1990-2006,” PLoS Neglected Tropical Diseases, vol. 5, no. 4, Article ID e1140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. B. Fowler, S. Stagno, R. F. Pass, W. J. Britt, T. J. Boll, and C. A. Alford, “The outcome of congenital cytomegalovirus infection in relation to maternal antibody status,” The New England Journal of Medicine, vol. 326, no. 10, pp. 663–667, 1992. View at Google Scholar · View at Scopus
  11. M. Lanari, M. G. Capretti, T. Lazzarotto et al., “Neuroimaging in CMV congenital infected neonates: how and when,” Early Human Development, vol. 88, supplement 2, pp. S3–S5, 2012. View at Google Scholar
  12. M. R. Schleiss, “Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis,” Infectious Disorders, vol. 11, no. 5, pp. 449–465, 2011. View at Google Scholar · View at Scopus
  13. K. Hamprecht, S. Witzel, J. Maschmann, C. P. Speer, and G. Jahn, “Transmission of cytomegalovirus infection through breast milk in term and preterm infants: the role of cell free milk whey and milk cells,” Advances in Experimental Medicine and Biology, vol. 478, pp. 231–239, 2000. View at Google Scholar · View at Scopus
  14. J. Maschmann, K. Hamprecht, K. Dietz, G. Jahn, and C. P. Speer, “Cytomegalovirus infection of extremely low-birth weight infants via breast milk,” Clinical Infectious Diseases, vol. 33, no. 12, pp. 1998–2003, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. A. Bowden, S. J. Slichter, M. Sayers et al., “A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant,” Blood, vol. 86, no. 9, pp. 3598–3603, 1995. View at Google Scholar · View at Scopus
  16. M. Dworsky, M. Yow, S. Stagno, R. F. Pass, and C. Alford, “Cytomegalovirus infection of breast milk and transmission in infancy,” Pediatrics, vol. 72, no. 3, pp. 295–299, 1983. View at Google Scholar · View at Scopus
  17. M. R. Schleiss, “Acquisition of human cytomegalovirus infection in infants via breast milk: natural immunization or cause for concern?” Reviews in Medical Virology, vol. 16, no. 2, pp. 73–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. M. Lanzieri, S. C. Dollard, C. D. Josephson, D. S. Schmid, and S. R. Bialek, “Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants,” Pediatrics, vol. 131, no. 6, pp. e1937–e1945, 2013. View at Google Scholar
  19. P. Gessler, G. A. Bischoff, D. Wiegand, B. Essers, and W. Bossart, “Cytomegalovirus-associated necrotizing enterocolitis in a preterm twin after breastfeeding,” Journal of Perinatology, vol. 24, no. 2, pp. 124–126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Nijman, L. S. de Vries, C. Koopman-Esseboom, C. S. P. M. Uiterwaal, A. M. van Loon, and M. A. Verboon-Maciolek, “Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings,” Archives of Disease in Childhood, vol. 97, no. 4, pp. F259–F263, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. G. Capretti, M. Lanari, T. Lazzarotto et al., “Very low birth weight infants born to cytomegalovirus-seropositive mothers fed with their mother's milk: a prospective study,” The Journal of Pediatrics, vol. 154, no. 6, pp. 842–848, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Bevot, K. Hamprecht, I. Krägeloh-Mann, S. Brosch, R. Goelz, and B. Vollmer, “Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk,” Acta Paediatrica, vol. 101, no. 4, pp. e167–e172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Vollmer, K. Seibold-Weiger, C. Schmitz-Salue et al., “Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants,” Pediatric Infectious Disease Journal, vol. 23, no. 4, pp. 322–327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Miller-Kittrell and T. E. Sparer, “Feeling manipulated: cytomegalovirus immune manipulation,” Virology Journal, vol. 6, article 4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. M. Mussi-Pinhata, A. Y. Yamamoto, R. M. M. Brito et al., “Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population,” Clinical Infectious Diseases, vol. 49, no. 4, pp. 522–528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. B. Boppana, K. B. Fowler, W. J. Britt, S. Stagno, and R. F. Pass, “Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus,” Pediatrics, vol. 104, no. 1, pp. 55–60, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Sung and M. R. Schleiss, “Update on the current status of cytomegalovirus vaccines,” Expert Review of Vaccines, vol. 9, no. 11, pp. 1303–1314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. D. Griffiths, “Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation,” The Lancet Infectious Diseases, vol. 12, no. 10, pp. 790–798, 2012. View at Google Scholar
  29. J. Johnson, B. Anderson, and R. F. Pass, “Prevention of maternal and congenital cytomegalovirus infection,” Clinical Obstetrics and Gynecology, vol. 55, no. 2, pp. 521–530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. R. Schleiss, “Cytomegalovirus vaccine development,” Current Topics in Microbiology and Immunology, vol. 325, pp. 361–382, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. T. G. Wegmann, H. Lin, L. Guilbert, and T. R. Mosmann, “Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?” Immunology Today, vol. 14, no. 7, pp. 353–356, 1993. View at Google Scholar · View at Scopus
  32. L. Sykes, D. A. MacIntyre, X. J. Yap, T. G. Teoh, and P. R. Bennett, “The Th1:th2 dichotomy of pregnancy and preterm labour,” Mediators of Inflammation, vol. 2012, Article ID 967629, 12 pages, 2012. View at Publisher · View at Google Scholar
  33. L. Sykes, D. A. MacIntyre, X. J. Yap, S. Ponnampalam, T. G. Teoh, and P. R. Bennett, “Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-Delta12,14-prostaglandin J2,” Mediators of Inflammation, vol. 2012, Article ID 416739, 12 pages, 2012. View at Publisher · View at Google Scholar
  34. S. Jost and M. Altfeld, “Control of human viral infections by natural killer cells,” Annual Review of Immunology, vol. 31, pp. 163–194, 2013. View at Google Scholar
  35. J. G. O'Leary, M. Goodarzi, D. L. Drayton, and U. H. von Andrian, “T cell- and B cell-independent adaptive immunity mediated by natural killer cells,” Nature Immunology, vol. 7, no. 5, pp. 507–516, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini, “Functions of natural killer cells,” Nature Immunology, vol. 9, no. 5, pp. 503–510, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. G. E. Lash, S. C. Robson, and J. N. Bulmer, “Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua,” Placenta, vol. 31, supplement, pp. S87–S92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Trowsdale and A. G. Betz, “Mother's little helpers: mechanisms of maternal-fetal tolerance,” Nature Immunology, vol. 7, no. 3, pp. 241–246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Manaster and O. Mandelboim, “The unique properties of uterine NK cells,” American Journal of Reproductive Immunology, vol. 63, no. 6, pp. 434–444, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Manaster, S. Mizrahi, D. Goldman-Wohl et al., “Endometrial NK cells are special immature cells that await pregnancy,” Journal of Immunology, vol. 181, no. 3, pp. 1869–1876, 2008. View at Google Scholar · View at Scopus
  41. P. F. Whitelaw and B. A. Croy, “Granulated lymphocytes of pregnancy,” Placenta, vol. 17, no. 8, pp. 533–543, 1996. View at Google Scholar · View at Scopus
  42. T. Strowig, F. Brilot, and C. Münz, “Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity,” Journal of Immunology, vol. 180, no. 12, pp. 7785–7791, 2008. View at Google Scholar · View at Scopus
  43. W. J. Muller, C. A. Jones, and D. M. Koelle, “Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn,” Current Immunology Reviews, vol. 6, no. 1, pp. 38–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Siewiera, H. El Costa, J. Tabiasco et al., “Human cytomegalovirus infection elicits new decidual natural killer cell effector functions,” PLoS Pathogens, vol. 9, no. 4, Article ID 100325, 2013. View at Google Scholar
  45. P. Le Bouteiller, J. Siewiera, Y. Casart et al., “The human decidual NK-cell response to virus infection: what can we learn from circulating NK lymphocytes?” Journal of Reproductive Immunology, vol. 88, no. 2, pp. 170–175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. C. A. Biron, K. S. Byron, and J. L. Sullivan, “Severe herpesvirus infections in an adolescent without natural killer cells,” The New England Journal of Medicine, vol. 320, no. 26, pp. 1731–1735, 1989. View at Google Scholar · View at Scopus
  47. S. Kohl, J. J. Frazier, S. B. Greenberg, L. K. Pickering, and L. S. Loo, “Interferon induction of natural killer cytotoxicity in human neonates,” The Journal of Pediatrics, vol. 98, no. 3, pp. 379–384, 1981. View at Google Scholar · View at Scopus
  48. D. E. Noyola, C. Fortuny, A. Muntasell et al., “Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children,” European Journal of Immunology, vol. 42, no. 12, pp. 3256–3266, 2012. View at Google Scholar
  49. S. McDonagh, E. Maidji, H.-T. Chang, and L. Pereira, “Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis,” Journal of Clinical Virology, vol. 35, no. 2, pp. 210–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. P. G. Quie, J. G. White, B. Holmes, and R. A. Good, “In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood,” The Journal of Clinical Investigation, vol. 46, no. 4, pp. 668–679, 1967. View at Google Scholar · View at Scopus
  51. N. Rai and N. Thakur, “Congenital CMV with LAD type 1 and NK cell deficiency,” Journal of Pediatric Hematology/Oncology, vol. 35, no. 6, pp. 468–469, 2013. View at Google Scholar
  52. A. Salvador, D. Najjar, and H. Hurt, “A preterm infant with a fatal congenital cytomegalovirus CMV infection,” Journal of Perinatology, vol. 10, no. 2, pp. 228–229, 1990. View at Google Scholar · View at Scopus
  53. D. A. Schwartz, R. Khan, and B. Stoll, “Characterization of the fetal inflammatory response to cytomegalovirus placentitis,” Archives of Pathology & Laboratory Medicine, vol. 116, no. 1, pp. 21–27, 1992. View at Google Scholar · View at Scopus
  54. Z. Liu, Y. Tian, B. Wang et al., “Serum proteomics with SELDI-TOF-MS in congenital human cytomegalovirus hepatitis,” Journal of Medical Virology, vol. 79, no. 10, pp. 1500–1505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Bácsi, J. Aranyosi, Z. Beck et al., “Placental macrophage contact potentiates the complete replicative cycle of human cytomegalovirus in syncytiotrophoblast cells: role of interleukin-8 and transforming growth factor-β1,” Journal of Interferon and Cytokine Research, vol. 19, no. 10, pp. 1153–1160, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Weisblum, A. Panet, Z.-R. Zichria et al., “Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture,” Journal of Virology, vol. 85, no. 24, pp. 13204–13213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Kumar, T. Kawai, and S. Akira, “Toll-like receptors and innate immunity,” Biochemical and Biophysical Research Communications, vol. 388, no. 4, pp. 621–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Kumar, T. Kawai, and S. Akira, “Pathogen recognition by the innate immune system,” International Reviews of Immunology, vol. 30, no. 1, pp. 16–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Kijpittayarit, A. J. Eid, R. A. Brown, C. V. Paya, and R. R. Razonable, “Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation,” Clinical Infectious Diseases, vol. 44, no. 10, pp. 1315–1320, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. S. H. Kang, R. C. Abdel-Massih, R. A. Brown, R. A. Dierkhising, W. K. Kremers, and R. R. Razonable, “Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation,” The Journal of Infectious Diseases, vol. 205, no. 4, pp. 639–646, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Chaudhuri, B. Lowen, G. Chan, A. Davey, M. Riddell, and L. J. Guilbert, “Human cytomegalovirus interacts with toll-like receptor 2 and CD14 on syncytiotrophoblasts to stimulate expression of TNFalpha mRNA and apoptosis,” Placenta, vol. 30, no. 11, pp. 994–1001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Chan and L. J. Guilbert, “Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumour necrosis factor-α dependent manner,” Journal of Pathology, vol. 210, no. 1, pp. 111–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. K. W. Boehme, M. Guerrero, and T. Compton, “Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells,” Journal of Immunology, vol. 177, no. 10, pp. 7094–7102, 2006. View at Google Scholar · View at Scopus
  64. L. K. Juckem, K. W. Boehme, A. L. Feire, and T. Compton, “Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells,” Journal of Immunology, vol. 180, no. 7, pp. 4965–4977, 2008. View at Google Scholar · View at Scopus
  65. A. Casrouge, S.-Y. Zhang, C. Eidenschenk et al., “Herpes simplex virus encephalitis in human UNC-93B deficiency,” Science, vol. 314, no. 5797, pp. 308–312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. S.-Y. Zhang, E. Jouanguy, S. Ugolini et al., “TLR3 deficiency in patients with herpes simplex encephalitis,” Science, vol. 317, no. 5844, pp. 1522–1527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Nahum, H. Dadi, A. Bates, and C. M. Roifman, “The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity,” Autoimmunity Reviews, vol. 11, no. 5, pp. 341–347, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Mezger, M. Bonin, T. Kessler, F. Gebhardt, H. Einsele, and J. Loeffler, “Toll-like receptor 3 has no critical role during early immune response of human monocyte-derived dendritic cells after infection with the human cytomegalovirus strain TB40E,” Viral Immunology, vol. 22, no. 6, pp. 343–351, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Arav-Boger, G. L. Wojcik, P. Duggal et al., “Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine,” BMC Research Notes, vol. 5, article 140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. I. Roth, D. B. Corry, R. M. Locksley, J. S. Abrams, M. J. Litton, and S. J. Fisher, “Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10,” The Journal of Experimental Medicine, vol. 184, no. 2, pp. 539–548, 1996. View at Google Scholar · View at Scopus
  71. G. M. Scott, S. S. W. Chow, M. E. Craig et al., “Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid,” The Journal of Infectious Diseases, vol. 205, no. 8, pp. 1305–1310, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Arsenescu, V. Arsenescu, and W. J. S. de Villiers, “TNF-α and the development of the neonatal immune system: implications for inhibitor use in pregnancy,” The American Journal of Gastroenterology, vol. 106, no. 4, pp. 559–562, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. J. P. Gisbert and M. Chaparro, “Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease,” The American Journal of Gastroenterology, 2013. View at Publisher · View at Google Scholar
  74. P. A. Velilla, M. T. Rugeles, and C. A. Chougnet, “Defective antigen-presenting cell function in human neonates,” Clinical Immunology, vol. 121, no. 3, pp. 251–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Drohan, J. J. Harding, B. Holm et al., “Selective developmental defects of cord blood antigen-presenting cell subsets,” Human Immunology, vol. 65, no. 11, pp. 1356–1369, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Renneson, B. Dutta, S. Goriely et al., “IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection,” European Journal of Immunology, vol. 39, no. 10, pp. 2789–2799, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Hassan, S. Dooley, and W. Hall, “Immunological response to cytomegalovirus in congenitally infected neonates,” Clinical and Experimental Immunology, vol. 147, no. 3, pp. 465–471, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. S. T. Hamilton, G. Scott, Z. Naing et al., “Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes,” PloS One, vol. 7, no. 12, Article ID e52899, 2012. View at Google Scholar
  79. P. Griffiths, S. Plotkin, E. Mocarski et al., “Desirability and feasibility of a vaccine against cytomegalovirus,” Vaccine, vol. 31, supplement 2, pp. B197–B203, 2013. View at Google Scholar
  80. S. Visentin, R. Manara, L. Milanese et al., “Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age,” Clinical Infectious Diseases, vol. 55, no. 4, pp. 497–503, 2012. View at Google Scholar
  81. E. Polilli, G. Parruti, F. D’Arcangelo et al., “Preliminary evaluation of the safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary cytomegalovirus infection,” Clinical and Vaccine Immunology, vol. 19, no. 12, pp. 1991–1993, 2012. View at Google Scholar
  82. M. Rola Pleszczynski, L. D. Frenkel, D. A. Fuccillo et al., “Specific impairment of cell mediated immunity in mothers of infants with congenital infection due to cytomegalovirus,” The Journal of Infectious Diseases, vol. 135, no. 3, pp. 386–391, 1977. View at Google Scholar · View at Scopus
  83. S. E. Starr, M. D. Tolpin, H. M. Friedman, K. Paucker, and S. A. Plotkin, “Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers,” The Journal of Infectious Diseases, vol. 140, no. 4, pp. 500–505, 1979. View at Google Scholar · View at Scopus
  84. T. Fujikawa, K. Numazaki, H. Asanuma, R. Kudo, and H. Tsutsumi, “Frequency of human cytomegalovirus-specific T cells during pregnancy determined by intracellular cytokine staining,” Journal of Medical Virology, vol. 71, no. 4, pp. 527–531, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. D. Lilleri, C. Fornara, M. Furione, M. Zavattoni, M. G. Revello, and G. Gerna, “Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus,” The Journal of Infectious Diseases, vol. 195, no. 7, pp. 1062–1070, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. M. G. Revello, D. Lilleri, M. Zavattoni et al., “Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers,” The Journal of Infectious Diseases, vol. 193, no. 2, pp. 269–276, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. H. Stern, G. Hannington, J. Booth, and D. Moncrieff, “An early marker of fetal infection after primary cytomegalovirus infection in pregnancy,” British Medical Journal, vol. 292, no. 6522, pp. 718–720, 1986. View at Google Scholar · View at Scopus
  88. S. Fernando, J. M. Pearce, and J. C. Booth, “Lymphocyte responses and virus excretion as risk factors for intrauterine infection with cytomegalovirus,” Journal of Medical Virology, vol. 41, no. 2, pp. 108–113, 1993. View at Publisher · View at Google Scholar · View at Scopus
  89. C. Fornara, D. Lilleri, M. G. Revello et al., “Kinetics of effector functions and phenotype of virus-specific and γδ T lymphocytes in primary human cytomegalovirus infection during pregnancy,” Journal of Clinical Immunology, vol. 31, no. 6, pp. 1054–1064, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. D. Lilleri, C. Fornara, M. G. Revello, and G. Gerna, “Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection,” The Journal of Infectious Diseases, vol. 198, no. 4, pp. 536–543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. W. Tu, S. Chen, M. Sharp et al., “Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children,” Journal of Immunology, vol. 172, no. 5, pp. 3260–3267, 2004. View at Google Scholar · View at Scopus
  92. T. Fujikawa, K. Numazaki, H. Asanuma, and H. Tsutsumi, “Human cytomegalovirus infection during pregnancy and detection of specific T cells by intracellular cytokine staining,” International Journal of Infectious Diseases, vol. 7, no. 3, pp. 215–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. N. Hayashi, H. Kimura, T. Morishima, N. Tanaka, T. Tsurumi, and K. Kuzushima, “Flow cytometric analysis of cytomegalovirus-specific cell-mediated immunity in the congenital infection,” Journal of Medical Virology, vol. 71, no. 2, pp. 251–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. A. K. Lidehall, M. L. Engman, F. Sund et al., “Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children,” Scandinavian Journal of Immunology, vol. 77, no. 2, pp. 135–143, 2013. View at Google Scholar
  95. O. Fornara, J. Odeberg, Z. Khan et al., “Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation,” Immunobiology, vol. 218, no. 8, pp. 1034–1040, 2013. View at Google Scholar
  96. A. Teles, A. C. Zenclussen, and A. Schumacher, “Regulatory T cells are baby's best friends,” American Journal of Reproductive Immunology, vol. 69, no. 4, pp. 331–339, 2013. View at Google Scholar
  97. J. H. Rowe, J. M. Ertelt, L. Xin, and S. S. Way, “Pregnancy imprints regulatory memory that sustains anergy to fetal antigen,” Nature, vol. 490, no. 7418, pp. 102–106, 2012. View at Google Scholar
  98. B. T. Rouse, P. P. Sarangi, and S. Suvas, “Regulatory T cells in virus infections,” Immunological Reviews, vol. 212, pp. 272–286, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. Y. Belkaid, “Regulatory T cells and infection: a dangerous necessity,” Nature Reviews Immunology, vol. 7, no. 11, pp. 875–888, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Egli, M. Silva Jr., D. O'Shea et al., “An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients,” PloS One, vol. 7, no. 11, Article ID e43937, 2012. View at Google Scholar
  101. E. M. Aandahl, J. Michaëlsson, W. J. Moretto, F. M. Hecht, and D. F. Nixon, “Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens,” Journal of Virology, vol. 78, no. 5, pp. 2454–2459, 2004. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Velaga, S. N. Ukena, M. Hopting et al., “Reconstitution and phenotype of Tregs in CMV reactivating patients following allogeneic hematopoietic stem cell transplantation,” Immunological Investigations, vol. 42, no. 1, pp. 18–35, 2013. View at Google Scholar
  103. C. La Rosa and D. J. Diamond, “The immune response to human CMV,” Future Virology, vol. 7, no. 3, pp. 279–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. M. R. Wills, A. J. Carmichael, K. Mynard et al., “The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL,” Journal of Virology, vol. 70, no. 11, pp. 7569–7579, 1996. View at Google Scholar · View at Scopus
  105. R. Elkington, S. Walker, T. Crough et al., “Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers,” Journal of Virology, vol. 77, no. 9, pp. 5226–5240, 2003. View at Publisher · View at Google Scholar · View at Scopus
  106. A. W. Sylwester, B. L. Mitchell, J. B. Edgar et al., “Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects,” The Journal of Experimental Medicine, vol. 202, no. 5, pp. 673–685, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. J. Hassan and J. Connell, “Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on,” Clinical and Experimental Immunology, vol. 149, no. 2, pp. 205–210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. L. Gibson, S. Donley, S. Trzmielina et al., “Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants,” The Journal of Infectious Diseases, vol. 195, no. 12, pp. 1789–1798, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. B. Pédron, V. Guérin, F. Jacquemard et al., “Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers,” The Journal of Infectious Diseases, vol. 196, no. 7, pp. 1033–1043, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. M. A. E. Ould, D. Luton, M. Yadini et al., “Cellular immune response of fetuses to cytomegalovirus,” Pediatric Research, vol. 55, no. 2, pp. 280–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Marchant, V. Appay, M. Van Der Sande et al., “Mature CD8+ T lymphocyte response to viral infection during fetal life,” The Journal of Clinical Investigation, vol. 111, no. 11, pp. 1747–1755, 2003. View at Google Scholar · View at Scopus
  112. A. Marchant and M. Goldman, “T cell-mediated immune responses in human newborns: ready to learn?” Clinical and Experimental Immunology, vol. 141, no. 1, pp. 10–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  113. P. G. Holt, “Functionally mature virus-specific CD8+ T memory cells in congenitally infected newborns: proof of principle for neonatal vaccination?” The Journal of Clinical Investigation, vol. 111, no. 11, pp. 1645–1647, 2003. View at Google Scholar · View at Scopus
  114. W. K. Born, N. Jin, M. K. Aydintug et al., “γδ T lymphocytes—selectable cells within the innate system?” Journal of Clinical Immunology, vol. 27, no. 2, pp. 133–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. D. Vermijlen, M. Brouwer, C. Donner et al., “Human cytomegalovirus elicits fetal γδ T cell responses in utero,” The Journal of Experimental Medicine, vol. 207, no. 4, pp. 807–821, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. R. F. Pass, C. H. Zhang, A. Evans et al., “Vaccine prevention of maternal cytomegalovirus infection,” The New England Journal of Medicine, vol. 360, no. 12, pp. 1191–1199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. P. D. Griffiths, A. Stanton, E. McCarrell et al., “Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial,” The Lancet, vol. 377, no. 9773, pp. 1256–1263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. S. Sabbaj, R. F. Pass, P. A. Goepfert, and S. Pichon, “Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women,” The Journal of Infectious Diseases, vol. 203, no. 11, pp. 1534–1541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. M. R. Schleiss, “Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?” The Journal of Infectious Diseases, vol. 203, no. 11, pp. 1513–1516, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. E. F. Chakravarty, E. R. Murray, A. Kelman, and P. Farmer, “Pregnancy outcomes after maternal exposure to rituximab,” Blood, vol. 117, no. 5, pp. 1499–1506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. L. Le Clech, J. C. Ianotto, I. Quintin-Roue, and A. Tempescul, “Severe CMV complication following maintenance therapy with rituximab,” BMJ Case Reports, 2013. View at Publisher · View at Google Scholar
  122. K. Ahlfors, S.-A. Ivarsson, and S. Harris, “Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature,” Scandinavian Journal of Infectious Diseases, vol. 31, no. 5, pp. 443–457, 1999. View at Publisher · View at Google Scholar · View at Scopus
  123. S. A. Ross, N. Arora, Z. Novak, K. B. Fowler, W. J. Britt, and S. B. Boppana, “Cytomegalovirus reinfections in healthy seroimmune women,” The Journal of Infectious Diseases, vol. 201, no. 3, pp. 386–389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. G. Nigro, S. P. Adler, R. La Torre, A. M. Best, and Congenital Cytomegalovirus Collaborating Group, “Passive immunization during pregnancy for congenital cytomegalovirus infection,” The New England Journal of Medicine, vol. 353, no. 13, pp. 1350–1362, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. F. P. McCarthy, M. L. Giles, S. Rowlands, K. J. Purcell, and C. A. Jones, “Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant,” Cochrane Database of Systematic Reviews, vol. 3, Article ID CD008371, 2011. View at Google Scholar · View at Scopus
  126. G. Nigro, R. La Torre, H. Pentimalli et al., “Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy,” Prenatal Diagnosis, vol. 28, no. 6, pp. 512–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. G. Nigro, S. P. Adler, G. Parruti et al., “Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy—a case-control study of the outcome in children,” The Journal of Infectious Diseases, vol. 205, no. 2, pp. 215–227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. A. E. Fouts, P. Chan, J. P. Stephan, R. Vandlen, and B. Feierbach, “Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin,” Journal of Virology, vol. 86, no. 13, pp. 7444–7447, 2012. View at Google Scholar
  129. H. Buxmann, O. M. Stackelberg, R. L. Schlosser et al., “Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis,” Journal of Perinatal Medicine, vol. 40, no. 4, pp. 439–446, 2012. View at Google Scholar
  130. R. La Torre, G. Nigro, M. Mazzocco, A. M. Best, and S. P. Adler, “Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease,” Clinical Infectious Diseases, vol. 43, no. 8, pp. 994–1000, 2006. View at Publisher · View at Google Scholar · View at Scopus
  131. E. Maidji, G. Nigro, T. Tabata et al., “Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection,” American Journal of Pathology, vol. 177, no. 3, pp. 1298–1310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. E. Maidji, S. McDonagh, O. Genbacev, T. Tabata, and L. Pereira, “Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis,” American Journal of Pathology, vol. 168, no. 4, pp. 1210–1226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  133. E. C. Neto, R. Rubin, J. Schulte, and R. Giugliani, “Newborn screening for congenital infectious diseases,” Emerging Infectious Diseases, vol. 10, no. 6, pp. 1069–1073, 2004. View at Google Scholar · View at Scopus